Jazz Pharmaceuticals (JAZZ) PT Raised to $275 at TD Cowen
Tweet
Share
E-mailGet Alerts JAZZ Hot Sheet
Price: $254.28 +2.24%
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
TD Cowen analyst Joseph Thome, Ph.D raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $275.00 (from $220.00) while maintaining a Buy rating.
You May Also Be Interested In
- Stella International Holdings (1836:HK) (SLNLF) PT Lowered to HK$10 at Macquarie
- Deere (DE) PT Raised to $585 at JPMorgan
- Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
